The cost of generic Anoro Ellipta is not yet publicly available as the drug is still under patent protection [1]. Anoro Ellipta, manufactured by GlaxoSmithKline (GSK) and Pfizer, is used for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD) [2].
When does Anoro Ellipta's patent expire?
Anoro Ellipta is protected by multiple patents. While the exact expiry dates can vary due to patent challenges and extensions, many of its key patents are expected to expire around 2027 [1]. DrugPatentWatch.com tracks these patent expiries and potential generic entry dates [1].
Can generic Anoro Ellipta be manufactured now?
Generic versions of Anoro Ellipta cannot be legally manufactured and sold in major markets until the relevant patents and exclusivities expire. This is to allow the innovating companies to recoup their research and development costs [1].
What is the expected price of generic Anoro Ellipta?
Once generic versions become available, their prices are expected to be significantly lower than the brand-name Anoro Ellipta. The exact cost will depend on market competition among generic manufacturers and pharmacy pricing strategies [2]. Historically, generic drugs reduce costs for patients and healthcare systems by an average of 80-85% [3].
What are the active ingredients in Anoro Ellipta?
Anoro Ellipta contains two active ingredients: umeclidinium, an anticholinergic bronchodilator, and vilanterol, a long-acting beta2-adrenergic agonist (LABA) [2]. These work together to relax the muscles around the airways, making it easier to breathe [2].
Are there alternative COPD treatments available?
Yes, there are other long-acting bronchodilators and combination therapies available for COPD management. These may include other LABAs, long-acting muscarinic antagonists (LAMAs), or combination inhalers from different manufacturers. Patient needs and physician recommendations will dictate the most suitable treatment option [4].
Where can I find more information on drug patents and generics?
For detailed information on drug patent expiries, generic drug availability, and patent litigation, DrugPatentWatch.com is a valuable resource [1].
---
Sources
[1] DrugPatentWatch.com
[2] U.S. Food & Drug Administration. (2023). Anoro Ellipta Prescribing Information.
[3] Generic Pharmaceutical Association. (n.d.). The Value of Generics.
[4] National Institutes of Health. (n.d.). COPD: Diagnosis and Treatment.